DiaMedica Therapeutics Inc
NASDAQ:DMAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
S
|
SM Energy Co
F:SJL
|
US |
|
Atlanta Braves Holdings Inc
F:E450
|
US |
|
T
|
Tialis Essential IT PLC
F:U6M
|
UK |
|
Delta Electronics Thailand PCL
SET:DELTA
|
TH |
|
Intercede Group PLC
OTC:IRCDF
|
UK |
|
M
|
Medco Energi Internasional Tbk PT
SWB:MEF
|
ID |
|
ALK-Abello A/S
OTC:AKBLF
|
DK |
Wall St Price Targets
DMAC Price Targets Summary
DiaMedica Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMAC's stock price target?
Price Target
15.81
USD
According to Wall Street analysts, the average 1-year price target for
DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.